| |
Latest 10 SEC filings (by transaction date) for NBIX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -12,587 | $81.05 |
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -7,231 | $81.49 |
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Common Stock | S - Open market or private sale | -12,587 | $133.36 |
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 12,587 | $81.05 |
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Common Stock | S - Open market or private sale | -7,231 | $133.36 |
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 7,231 | $81.49 |
Apr 3/24 | Apr 1/24 | Delaet Ingrid | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -272 | $79.02 |
Apr 3/24 | Apr 1/24 | Delaet Ingrid | Direct Ownership | Common Stock | S - Open market or private sale | -272 | $137.30 |
Apr 3/24 | Apr 1/24 | Delaet Ingrid | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 272 | $79.02 |
Mar 25/24 | Mar 21/24 | Delaet Ingrid | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | $103.52 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for NBIX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -12,587 | $81.05 |
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -7,231 | $81.49 |
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Common Stock | S - Open market or private sale | -12,587 | $133.36 |
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 12,587 | $81.05 |
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Common Stock | S - Open market or private sale | -7,231 | $133.36 |
Apr 17/24 | Apr 15/24 | Benevich Eric | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 7,231 | $81.49 |
Apr 3/24 | Apr 1/24 | Delaet Ingrid | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -272 | $79.02 |
Apr 3/24 | Apr 1/24 | Delaet Ingrid | Direct Ownership | Common Stock | S - Open market or private sale | -272 | $137.30 |
Apr 3/24 | Apr 1/24 | Delaet Ingrid | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 272 | $79.02 |
Mar 25/24 | Mar 21/24 | Delaet Ingrid | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | $103.52 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |
Vertex Pharmaceuticals (OQ:VRTX) |